Page 59 - Retail Pharmacy November/Decemeber 2020

58 ANNUAL REPORT PRESCRIPTION REPORT Ranked by value of change APIXABAN IRON FERRIC DARBEPOETIN ALFA RIVAROXABAN METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA Top 5 corporate % shares BRISTOLMYER SQUIBB BAYER PHARMA VIFOR PHARMA BOEHRINGER INGELHM ASTRAZENECA CARDIOVASCULAR SYSTEM Value of change ($) $44,274,109 $12,111,228 $5,541,713 $5,039,938 $2,802,454 Pharmacy Volume Volume Change Value of change ($) $4,205,212 $5,167,959 $8,419,590 $21,652,420 $5,419,695 Value of change ($) $21,652,420 $8,419,590 $6,069,475 $5,419,695 $5,224,800 Value Change (%) 22% 20% 36% 3% 23% Value ($) $213,043,979 $156,190,859 $68,619,481 $44,583,096 $30,349,481 Volume change (%) 22% 15% 38% 9% 34% Volume (units) 2,607,852 2,143,429 454,669 736,715 246,510 ALIMENTARY TRACT AND METABOLISM Pharmacy Value Value Change Top 5 Molecules by Value ESOMEPRAZOLE PANTOPRAZOLE METFORMIN + SITAGLIPTIN PHENTERMINE METFORMIN Top molecule growth YoY ESOMEPRAZOLE PANTOPRAZOLE METFORMIN + SITAGLIPTIN PHENTERMINE METFORMIN Ranked by value of change $1,602,493,072 5% Pharmacy Volume Volume Change Value of change ($) -$5,953,871 $17,178,712 $4,648,710 $1,564,141 $6,106,727 Value of change ($) $30,477,084 $17,178,712 $16,753,114 $11,798,774 $8,913,705 57,328,434 3% Pharmacy Value Value Change Top 5 Molecules by Value APIXABAN RIVAROXABAN IRON FERRIC DABIGATRAN ETEXILATE CLOPIDOGREL Top molecule growth YoY APIXABAN RIVAROXABAN IRON FERRIC DABIGATRAN ETEXILATE CLOPIDOGREL $729,701,806 10% 11,085,634 5% Value ($) $194,440,213 $118,925,521 $85,310,775 $83,188,192 $75,899,958 Value Change (%) -3% 14% 5% 2% 8% Value Change (%) 100% 17% 83% 26% 25% Value ($) $162,875,781 $143,948,977 $114,244,292 $93,282,250 $87,760,506 Volume (units) 10,650,581 9,100,218 1,566,448 691,433 5,359,224 Volume change (%) 2% 13% 7% 6% 6% Volume change (%) 99% 15% 82% 29% 28% Volume (units) 3,082,222 2,791,982 4,664,325 2,181,119 1,169,371 Pharmacy Value Value Change Top 5 Molecules by Value ROSUVASTATIN ATORVASTATIN PERINDOPRIL SACUBITRIL + VALSARTAN CANDESARTAN CILEXETIL Top molecule growth YoY ROSUVASTATIN ATORVASTATIN PERINDOPRIL SACUBITRIL + VALSARTAN CANDESARTAN CILEXETIL Ranked by value of change SACUBITRIL + VALSARTAN PERINDOPRIL AMLODIPINE CANDESARTAN CILEXETIL TELMISARTAN Top 5 corporate % shares NOVARTIS APOTEX MSD MYLAN AUSTRALIA ASTRAZENECA $1,831,071,019 4% 101,455,500 4% DULAGLUTIDE PANTOPRAZOLE INSULIN ASPART + INSULIN DEGLUDEC EMPAGLIFLOZIN EMPAGLIFLOZIN + METFORMIN Top 5 corporate % shares NOVO-NORDISK BOEHRINGER INGELHM ASTRAZENECA MSD INOVA Value ($) $196,927,843 $143,413,642 $95,049,541 $73,043,752 $59,062,879 Value Change (%) 2% 4% 9% 30% 9% Value Change (%) 42% 10% 13% 10% 10% Value ($) $94,519,488 $92,194,267 $80,581,283 $78,732,210 $64,312,855 Volume (units) 12,619,294 11,204,658 6,766,456 365,660 3,724,737 Volume change (%) 6% 3% 3% 29% 7% Volume change (%) 41% 3% 13% 7% 7% Volume (units) 2,411,312 20,839,213 4,367,116 17,982,976 6,275,607 ANTINEOPLASTIC AND IMMUNOMODULATING Pharmacy Value Value Change Top 5 Molecules by Value ADALIMUMAB USTEKINUMAB ETANERCEPT IBRUTINIB ENZALUTAMIDE Top molecule growth YoY ADALIMUMAB USTEKINUMAB ETANERCEPT IBRUTINIB ENZALUTAMIDE Ranked by value of change PALBOCICLIB USTEKINUMAB TOFACITINIB IBRUTINIB OSIMERTINIB Top 5 corporate % shares JANSSEN CILAG ABBVIE NOVARTIS PFIZER ASTELLAS PHARMA AU $2,033,485,445 9% Pharmacy Volume Volume Change Value of change ($) -$9,861,780 $26,161,271 $263,378 $12,101,658 $3,844,970 Value of change ($) $37,517,137 $26,161,271 $15,562,657 $12,101,658 $9,913,540 Pharmacy Volume Volume Change Value of change ($) $44,274,109 $5,039,938 $12,111,228 -$207,677 $1,422,316 24,906,781 7% Value ($) $304,160,733 $194,826,696 $108,510,990 $108,245,233 $92,964,035 Value Change (%) -3% 13% 0% 11% 4% Value Change (%) 315% 16% 23% 13% 92% Value ($) $442,128,933 $338,262,876 $310,826,447 $237,067,657 $105,593,444 Volume (units) 246,435 48,109 105,803 11,869 25,912 Volume change (%) 5% 18% 0% 11% 7% Volume change (%) 316% 22% 23% 12% 92% Volume (units) 908,218 275,123 359,813 3,886,430 93,344 GENITO-URINARY SYSTEM AND SEX HORMONES Pharmacy Value Value Change Top 5 Molecules by Value SILDENAFIL $667,675,424 -5% Pharmacy Volume Volume Change Value of change ($) -$44,611,828 $5,837,936 $2,446,009 -$3,667,338 $845,848 Value of change ($) $5,837,936 $2,813,318 $2,446,009 $1,992,633 $1,824,444 Pharmacy Volume Volume Change 17,729,715 1% BLOOD AND BLOOD-FORMING ORGANS DUTASTERIDE + TAMSULOSIN LEVONORGESTREL TADALAFIL ESTRADIOL Top molecule growth YoY SILDENAFIL DUTASTERIDE + TAMSULOSIN LEVONORGESTREL TADALAFIL ESTRADIOL Ranked by value of change DUTASTERIDE + TAMSULOSIN FOLLITROPIN BETA LEVONORGESTREL PROGESTERONE TAMSULOSIN Top 5 corporate % shares BAYER PHARMA UPJOHN MSD LILLY ASTELLAS PHARMA AU SYSTEMIC ANTI-INFECTIVES Value ($) $84,899,391 $49,839,772 $47,427,270 $48,110,774 $40,239,471 Value Change (%) -53% 12% 5% -8% 2% Value Change (%) 13% 55% 5% 21% 7% Value ($) $103,524,916 $57,720,789 $48,529,682 $42,226,752 $35,551,004 Volume (units) 1,791,107 1,587,497 1,105,377 346,064 1,670,489 Volume change (%) 3% 12% 4% 6% 2% Volume change (%) 14% 56% 4% 24% 8% Volume (units) 2,447,237 646,928 581,843 325,797 611,365 Value ($) $242,861,946 $177,433,147 $72,492,627 $41,418,419 $34,799,629 Value Change (%) 18% 3% 17% -1% 4% Volume (units) 2,607,852 2,143,429 456,778 535,179 2,286,284 Volume change (%) 18% 8% 13% 5% 3% Pharmacy Value Value Change $897,075,206 -16% 84,902,382 -5% RETAIL PHARMACY • NOV/DEC 2020